Myotonia Congenita Clinical Trials

Find Myotonia Congenita Clinical Trials Near You

Convenient Quantification of Myopathic Change in Muscle Via Electrical Impedance Myography

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This study is being done to further develop a device, the mScan, to measure muscle health as compared to measurements of muscle health using MRI (magnetic resonance imaging). This device is held against the skin and uses Electrical Impedance Myography (EIM). EIM uses a very small, noninvasive (e.g. no needles), brief (about 6 seconds), and painless electrical current to measure the muscle. The investigators will look at how the mScan predicts the muscle measurements seen on MRI in people with and without muscle disease. The investigators hope that this can be used in the future as a quick, convenient and less time-consuming way than MRI to assess muscle health. This could be used to measure how well treatments for different muscle disorders are working over a period of time.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 89
Healthy Volunteers: t
View:

• Ages 18-89

• Evidence of a primary myopathic condition as determined by detailed chart review, including results of genetic testing, serological data, or previous muscle biopsy

Locations
United States
Massachusetts
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Time Frame
Start Date: 2025-04-09
Estimated Completion Date: 2027-09
Participants
Target number of participants: 150
Treatments
Healthy Control
Myopathy
Participants with Myopathies
Sponsors
Collaborators: Myolex, Inc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Leads: Beth Israel Deaconess Medical Center

This content was sourced from clinicaltrials.gov